Professional Documents
Culture Documents
KIDNEY
INJURY
POST RENAL
A I S YA H N A U L I S I H O TA N G
F A K U LT A S K E D O K T E R A N
C 111 12 128
I L M U P E N YA K I T D A L A M
IDENTITAS PASIEN
Nama
: Tn. AA
: 46 tahun
Pekerjaan : PNS
Alamat: BTN Griya Alauddin Permai
ANAMNESIS
Keluhan Utama : Nyeri pinggang kiri atas
Anamnesis Terpimpin : Nyeri pinggang disebelah kiri atas dirasakan sejak dua minggu
yang lalu hilang timbul, nyeri seperti tertusuk-tusuk dan terasa tembus ke belakang. Nyeri
dirasakan terutama pada pagi hari dan pada saat nyeri, pasien tidak mampu beraktivitas.
Nyeri berkurang dengan obat anti nyeri. Tidak ada keluhan yang sama sebelumnya.
Anamnesis Sistematik : Demam menggigil tidak ada, sakit kepala tidak ada, sakit menelan
tidak ada, batuk tidak ada, sesak tidak ada, nyeri dada tidak ada, nyeri ulu hati tidak ada,
mual muntah tidak ada, pasien mengaku BAK sedikit, frekuensi jarang, warna kuning tua
dan agak kasar sehingga pasien merasa tidak nyaman saat berkemih, minum 5 gelas
sehari. BAB konsistensi lunak, frekuensi normal. Pasien juga mengeluh nyeri sendi terus
menerus terutama sendi jari tangan dan kaki disertai benjolan sejak 3 bulan, berobat 2
hari yang lalu di RSUD Syekh Yusuf dan mendapat Allopurinol 100 mg. Riwayat Hipertensi
ada sejak tahun 2012 tidak terkontrol, berobat dengan amlodipine 10 mg. Riwayat DM
tidak ada. Riwayat merokok ada sejak muda, sudah berhenti 10 tahun yang lalu.
PEMERIKSAAN FISIS
General status:
BB : 55 kg
TB : 157 cm
: 170/100 mmHg
: 36.5 oC
VAS
: 3/10
PEMERIKSAAN FISIS
Head Examination
Konjungtiva : Anemis ()
Skera : Ikterik ()
Bibir
: Sianosis ()
Leher : Lymphadenopathy (), JVP
R + 0 cmH2O (30)
Thorax Examination
PEMERIKSAAN FISIS
Pemeriksaan Abdomen
Insp.
Pemeriksaan Punggung
Insp.
: Normal
Ausc. : Normal
Palp. : Normal
Perc. : Nyeri ketok tidak ada
Ekstremitas
Edema: -/-, Krepitasi -/-, limited ROM pada pedis d/s, hangat pada
perabaan -/-
LABORATORIUM
2-10-2016 RSUD Syekh Yusuf
Hb : 12,4 gr/dl
Ureum : 69 mg/dl
Creatinine : 1,5 mg/dl
Asam urat : 9,3 mg/dl
4-10-2016
HEMATOLOGY
WBC
RBC
HGB
HCT
MCV
MCH
MCHC
PLT
Ureum
Creatinin
SGOT
SGPT
Uric Acid
Natrium
Kalium
Klorida
RESULT
20,2
4,22
11,6
37
87
27
31
240
123
4,11
18
22
8,7
139
3,5
104
NORMAL VALUE
4.00-10.00
4.00-6.00
12.0-16.0
37.0-48.0
80.0-97.0
26.5-33.5
31.5-35.0
150-400
10-50
M(<1,3); F(<1.1)
<48
<41
F(2.4-5.7); M(3.4-7)
136-145
3.5-5.1
97-111
DIAGNOSIS KERJA
Acute Kidney Injury Stage 3 DD
s/ Nephropathy Obstruksi
Gout Arthritis
Hipertensi on treatment
TERAPI
Diet rendah garam, purin, kalium, protein
Amlodipine 10 mg/24 jam/oral
Allopurinol 100 mg/24 jam/oral
RENCANA PEMERIKSAAN
USG Abdomen
Urinalisa
X-Ray Ekstremitas
DISKUSI
ACUTE KIDNEY
I N J U RY
DEFINISI
Acute kidney injury (AKI) : Penurunan fungsi
ginjal yang terjadi secara mendadak (<48 jam)
Biasanya ditandai dengan :
1. Peningkatan kreatinin >0,5 mg% jika
kreatinin awal <2,5 mg% atau peningkatan
kreatinin >20% jika kreatinin awal >2,5 mg
%
2. Penurunan urin output (<0,5 ml/kgbb/jam
selama 6 jam)
KLASIFIKASI AKI
Stage
1
2
3
Serum creatinine
Urine output
Stage
Cr Criteria
UOP
Criteria
1.5-1.9 baseline
<0.5
ml/kg/hr
for 6-12 hrs
OR
1>0.3 mg/dL
Crby1.5-2x baseline or < 0.5 ml/kg/hr
Crby 0.3 mg/dl
for 6hr
<0.5 ml/kg/hr > 12 hrs
2-2.9 baseline
2
Crby 2-3x
< 0.5 ml/kg/hr
for 12hr
3 times baseline
<0.3
ml/kg/hr > 24 hrs
3OR
Crby more than 3x or
Crby
if baseline
increase
in Cr 0.5
to 4.0
mg/dL
>4mg/dl
OR
Initiation of RRT
KLASIFIKASI AKIN
Stage
1
2
3
Serum creatinine
Urine output
Stage
Cr Criteria
UOP
Criteria
1.5-2 baseline
<0.5
ml/kg/hr
for hrs
OR
1>0.3 mg/dL
Crby1.5-2x baseline or < 0.5 ml/kg/hr
Crby 0.3 mg/dl
for 6hr
<0.5 ml/kg/hr > 12 hrs
>2-3.0 baseline
2
Crby 2-3x
< 0.5 ml/kg/hr
for 12hr
>3x times baseline
<0.3
ml/kg/hr > 24 hrs
3OR
Crby more than 3x or
Crby
if baseline
increase
in Cr 0.5
to 4.0
mg/dL
>4mg/dl
OR
Need for RRT
EPIDEMIOLOGI
5-10% pada pasien rawat
inap
70% pada pasien sakit berat
5-6% pasien ICU memerlukan
RRT (Renal Replacement
Therapy)
Harrisons Ed.19th. Acute Kidney Injury. Sushrut S.W, Joseph V.B. 2015
AKI PRERENAL
Penurunan Volume Cairan
Intravaskular
Extracellular fluid loss: burns, diarrhea, vomiting,
diuretics, salt-wasting renal disease, primary
adrenal insufficiency, gastrointestinal hemorrhage
Extracellular fluid sequestration: pancreatitis,
burns, crush, injury, nephrotic syndrome,
malnutrition, advanced liver disease
AKI PRERENAL
Penurunan Cardiac Output
Myocardial dysfunction: MI, arrhythmias, ischemic
heart disease, cardiomyopathies, valvular disease,
hypertensive disease, severe cor pulmonale
Vasodilatasi Perifer
Drugs: antihypertensive agents
Sepsis,
Miscellaneous: adrenal cortical insufficiency,
hypermagnesemia, hypercapnia, hypoxia
AKI PRERENAL
Vasokonstriksi Renal Berat
Sepsis
Drugs: nonsteroidal anti-inflammatory agents,
-adrenergic agonists.
Hepatorenal syndrome
Ischemia
associat
ed AKI
Laboratory Features
BUN/creatinine ratio above 20,
FeNa
<1%, hyaline casts in urine
sediment,
urine specific gravity >1.018,
urine
osmolality >500 mOsm/kg
Comments
Low FeNa, high specific gravity
and
osmolality may not be seen in
the
setting of CKD, diuretic use; BUN
elevation out of proportion to
creatinine
may alternatively indicate upper
GI bleed or increased catabolism.
Response to restoration of
hemodynamics
is most diagnostic.
AKI RENAL
Harrisons Ed.19th. Acute Kidney Injury. Sushrut S.W, Joseph V.B. 2015
Harrisons Ed.19th. Acute Kidney Injury. Sushrut S.W, Joseph V.B. 2015
Sepsis (48%)
Ischemia (32%)
prolonged prerenal
azotemia
Hypotension
hypovolemic shock
cardiopulmonary arrest
cardiopulmonary bypass
PATO P H Y S I O L O G I A C U T E T U B U L A R N E C R O S I S
Prerenal
Azotemia
>20:1
10-15:1
<20
>40
Urine osmolality,
mosmol/L H2O
>500
<400
-Fractional
excretion of sodium
(FENa)
<1%
>2%
-FEUrea
<35%
Response to volume
Urinary Sediment
Bland, Hyaline
>35%
Cr wont improve much
Muddy brown granular
casts, cellular debris,
tubular epithelial cells
immobilization
creatine kinase;
urine heme
positive with
few red
blood cells
Hemolysi Recent blood
Anemia,
s
transfusion with
elevated LDH,
transfusion
low haptoglobin
reaction
Tumor
Recent
Hyperphosphate
lysis
chemotherapy
mia,
hypocalcemia,
hyperuricemia
Multiple
Age >60 years,
Monoclonal
myeloma constitutional
spike in urine or
Comments
FeNa may be low
(<1%)
Bone marrow or
renal biopsy can be
Tubular
injury
Interstitial
nephritis
Aminoglycoside antibiotics,
cisplatin,
tenofovir, zoledronate,
ethylene glycol,
aristolochic acid, and
melamine (to
name a few)
Recent medication exposure;
can have
fever, rash, arthralgias
Laboratory Features
Comments
Characteristic course is FeNa may be low (<1%)
rise in SCr
within 12 d, peak
within 35 d,
recovery within 7 d
Urine sediment often
Can be oliguric or
contains granular
nonoliguric
casts, renal tubular
epithelial cell
casts. FeNa typically
>1%.
Eosinophilia, sterile
Urine eosinophils have
pyuria; often
limited diagnostic
nonoliguric
accuracy; systemic signs of
Laboratory
Features
Glomerulon Variable features
ANA, ANCA, AGBM
ephritis/va include
antibody, hepatitis
sculitis
skin rash, arthralgias,
serologies,
sinusitis (AGBM
cryoglobulins,
disease), lung
blood culture,
hemorrhage (AGBM,
decreased
ANCA, lupus), recent
complement
skin infection or
levels,
pharyngitis
ASO titer
(poststreptococcal)
(abnormalities of
these tests
depending on
etiology)
Interstitial Nondrug-related causes Eosinophilia,
nephritis
include tubulointerstitial sterile pyuria;
Comments
Kidney biopsy may be
necessary
Atheroembolic
disease
Laboratory
Features
Neurologic abnormalities and/or Schistocytes
AKI;
on peripheral
recent diarrheal illness; use of
blood
calcineurin
smear,
inhibitors; pregnancy or
elevated LDH,
postpartum;
anemia,
Spontaneous
thrombocytop
enia
Hypocomplem
entemia,
eosinophiluria
(variable),
variable
amounts of
proteinuria
Comments
Typical HUS refers to AKI with a diarrheal
prodrome, often due to Shiga
toxin released from Escherichia coli or
other bacteria; atypical HUS is due
to inherited or acquired complement
dysregulation. TTP-HUS refers to
sporadic cases in adults. Diagnosis
may involve screening for ADAMTS13
activity, Shiga toxinproducing E. coli,
genetic evaluation of complement
regulatory proteins, and kidney
biopsy.
Skin or kidney biopsy can be diagnostic
AKI POSTRENAL
Level of obstruction
Upper tract (ureters)
Lower tract (bladder outlet or
urethra)
Degree of obstruction
Partial vs. Completee
Anatomic lesion (unilateral vs.
bilateral)
Functional
Duration (Acute vs
Chronic)
Cause (Congenital vs
Acquired)
LOWER TRACT
OBSTRUCTION
BPH or prostate
cancer
Bladder cancer
Urethral strictures
Bladder stones
Blood clots
Functional
obstruction as a
result of neurogenic
bladder
Intrinsic:
Nephrolithiasi
s
Blood clot
Papillary
necrosis
Cancer
Extrinsic:
Retroperitoneal or
pelvic malignancy
Endometriosis/Prol
apsed uterus
Abdominal aortic
aneurysm or Iliac
artery aneurysm
Retroperitoneal
fibrosis
Laboratory
Features
History of kidney stones, No specific
prostate
findings other than
disease, obstructed
AKI;
bladder catheter,
may have pyuria
retroperitoneal or pelvic or hematuria
neoplasm
Comments
Imaging with computed
tomography
or ultrasound
COMPLICATIONS OF AKI
Intravascular overload
Electrolyte disturbance
Hyperkalemia (serum K+ >5.5 mEq/L)
Hyponatremia (serum Na+ < 135 mEq/L)
Hyperphosphatemia (serum phosphate concentration of
>5.5 mg /dl)
Hypocalcemia (serum Ca++ < 8.5 mg/dl)
Hypercalcemia (serum Ca++ > 10.5 mg /dl)
PENCEGAHAN AKI
Renal AKI can be avoided: close attention to
cardiovascular function and intravascular volume in
high-risk patients (elderly & preexisting renal
insufficiency)
Aggressive restoration of intravascular
volume renal AKI after major surgery,
trauma or burns.
Nephrotoxic: tailoring the dosage of
potential nephrotoxins to body size and GFR
MANAGEMENT OF AKI
Preliminary measures
Exclusion of reversible causes: Obstruction should be relived,
infection should be treated
Correction of prerenal factors: intravascular volume and cardiac
performance should be optimized
Maintenance of urine output: Loop diuretics may be
usefully to convert the oliguric form of ATN to the
nonoliguric form.
High doses of loop diuretics such as Furosemide (up
to 200 to 400 mg intravenously) may promote diuresis
in patients who fail to respond to conventional doses
T E R A P I KON S E R VATI F
1. MANAGEMENT DIET
Protein 1.25 g/kgBB untuk menjaga
balance nitrogen.
Membatasi diet protein 0.6 0.8 g/kg
perhari misalnya protein yang high
biologic value (kaya asam amino esensial)
untuk azotemia berat.
2 . F L U I D A N D E L E C T R O LYT E M A N A G E M E N T
After hypovolemia corrected, total oral and
intravenous fluid administration = daily sensible
losses (via urine, stool, and NG tune o surgical
drainage)+estimated IWL (400500 ml/day).
Strict input output monitoring is
Hypervolemia: can usually be managed
by restriction of salt and water intake and
diuretics.
Hyperkalemia:
Restrict dietary K+ intake
Give calcium gluconate 10 ml of 10% solution over
5 minutes
Glucose solution 50 ml of 50 % glucose plus
Insulin 10 units IV
Potassiumbinding ion exchange resin
Dialysis: therapy fails or the patient is very toxic
Hyperphosphatemia:
restriction
of
dietary
phosphate and by oral aluminum hydroxide or
calcium carbonate, which reduce gastrointestinal
absorption of phosphate.
Hypocalcemia does not usually require treatment.
PROGNOSIS
Tergantung berat-ringannya penyakit
yang mendasari dan manifestasi klinisnya
Morbiditas dan Mortalitas: dipengaruh dari ada
tidaknya oliguria, GI bleeding, septicemia,
metabolic acidosis and neurologic abnormalities
(pasien oliguric > nonoliguric ).
Mortality rate: oliguric=50 %,
nonoliguric= 26 %
THANK
YOU
THANK YOU...